Infantile onset carnitine palmitoyltransferase 2 deficiency: Cortical polymicrogyria, schizencephaly, and gray matter heterotopias in an adolescent with normal development.
CPT2
carnitine
cerebral
heterotopias
infantile
malformation
palmitoyltransferase
polymicrogyria
Journal
JIMD reports
ISSN: 2192-8304
Titre abrégé: JIMD Rep
Pays: United States
ID NLM: 101568557
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
25
05
2020
revised:
21
06
2021
accepted:
19
07
2021
entrez:
14
1
2022
pubmed:
15
1
2022
medline:
15
1
2022
Statut:
epublish
Résumé
To report an adolescent with infantile-onset carnitine palmitoyltransferase 2 (CPT2) deficiency and cerebral malformations and to review the occurrence of brain malformations in CPT2 deficiency. The patient presented clinically at age 5 months with dehydration and hepatomegaly. He also has an unrelated condition, X-linked nephrogenic diabetes insipidus. He had recurrent rhabdomyolysis but normal psychomotor development. At age 17 years, he developed spontaneous focal seizures. Cerebral magnetic resonance imaging revealed extensive left temporo-parieto-occipital polymicrogyria, white matter heterotopias, and schizencephaly. Neuronal migration defects were previously reported in lethal neonatal CPT2 deficiency but not in later-onset forms. We searched PubMed, Google Scholar, and the bibliographies of the articles found by these searches, for cerebral malformations in CPT2 deficiency. All antenatal, neonatal, infantile, and adult-onset cases were included. Exclusion criteria included insufficient information about age of clinical onset and lack of confirmation of CPT2 deficiency by enzymatic assay or genetic testing. For each report, we noted the presence of cerebral malformations on brain imaging or pathological examination. Of 26 neonatal-onset CPT2-deficient patients who met the inclusion criteria, brain malformations were reported in 16 (61.5%). In 19 infantile-onset cases, brain malformations were not reported, but only 3 of the 19 reports (15.8%) include brain imaging or neuropathology data. In 276 adult-onset cases, no brain malformations were reported. To the best of our knowledge, this is the first report of cerebral malformations in an infantile onset CPT2-deficient patient. Brain imaging should be considered in patients with CPTII deficiency and neurological manifestations, even in those with later clinical onset.
Identifiants
pubmed: 35028265
doi: 10.1002/jmd2.12243
pii: JMD212243
pmc: PMC8743346
doi:
Types de publication
Case Reports
Langues
eng
Pagination
3-10Informations de copyright
© 2021 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM.
Déclaration de conflit d'intérêts
Ivan Shelihan, Elsa Rossignol, Jean‐Claude Décarie, Jean‐Paul Bonnefont, Michèle Brivet, Catherine Brunel‐Guitton, and Grant A. Mitchell declare that they have no conflict of interest.
Références
J Hum Genet. 2003;48(1):8-13
pubmed: 12560872
Hum Mutat. 2003 May;21(5):493-501
pubmed: 12673791
Neuromuscul Disord. 2007 Dec;17(11-12):960-3
pubmed: 17651973
Pediatr Neurol. 2000 Feb;22(2):148-50
pubmed: 10738923
Turk J Pediatr. 2007 Apr-Jun;49(2):120-30
pubmed: 17907510
Hum Mutat. 1998;11(5):377-86
pubmed: 9600456
Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8429-33
pubmed: 1528846
Kidney Int. 1994 Jul;46(1):170-6
pubmed: 7933835
JIMD Rep. 2021 Sep 29;63(1):3-10
pubmed: 35028265
J Neurol Sci. 2014 Mar 15;338(1-2):107-11
pubmed: 24398345
Clin Genet. 2012 Sep;82(3):232-9
pubmed: 21913903
J Clin Invest. 1991 Mar;87(3):859-64
pubmed: 1999498
Mol Genet Metab. 2011 Nov;104(3):414-6
pubmed: 21641254
Am J Med Genet. 1989 Mar;32(3):395-401
pubmed: 2658591
Neuromuscul Disord. 1995 Mar;5(2):129-37
pubmed: 7767092
Eur J Pediatr. 2010 Dec;169(12):1561-3
pubmed: 20661589
Am J Perinatol. 2003 Jan;20(1):25-32
pubmed: 12638078
Tohoku J Exp Med. 2010 Jul;221(3):191-5
pubmed: 20543534
Mol Genet Metab. 1998 Aug;64(4):229-36
pubmed: 9758712
Hum Mutat. 1999;13(3):210-20
pubmed: 10090476
Mol Genet Metab. 2008 Aug;94(4):422-427
pubmed: 18550408
Am J Hum Genet. 1996 May;58(5):971-8
pubmed: 8651281
Am J Hum Genet. 1994 Aug;55(2):278-86
pubmed: 8037205
J Inherit Metab Dis. 2007 Apr;30(2):266
pubmed: 17372854
Pediatrics. 2001 Jun;107(6):E103
pubmed: 11389301
Am J Med Genet. 2001 Aug 1;102(2):183-7
pubmed: 11477613
J Neurol Sci. 2005 Dec 15;239(1):21-4
pubmed: 16168441
J Pediatr. 2002 Nov;141(5):734-6
pubmed: 12410208
Lab Invest. 2003 Nov;83(11):1543-54
pubmed: 14615409
Mol Genet Metab. 2006 Dec;89(4):323-31
pubmed: 16996287
Prenat Diagn. 2003 Nov;23(11):884-7
pubmed: 14634971
Mol Aspects Med. 2004 Oct-Dec;25(5-6):495-520
pubmed: 15363638
Mol Genet Metab. 2011 Apr;102(4):399-406
pubmed: 21227726
Brain Dev. 1994 Mar-Apr;16(2):139-45
pubmed: 8048703
J Pediatr. 1993 Jun;122(6):917-9
pubmed: 8501570
J Neurol. 2013 May;260(5):1412-4
pubmed: 23475205
Clin Genet. 2008 May;73(5):496-501
pubmed: 18363739
Clin Pediatr (Phila). 1999 Jan;38(1):13-20
pubmed: 9924637
J Inherit Metab Dis. 1995;18(3):362-3
pubmed: 7474909
Clin Genet. 2016 Feb;89(2):193-7
pubmed: 25827434
Can J Neurol Sci. 2005 Aug;32(3):316-20
pubmed: 16225172
J Neurol Sci. 2008 Mar 15;266(1-2):97-103
pubmed: 17936304
Pediatr Dev Pathol. 2009 Nov-Dec;12(6):481-6
pubmed: 19335026
Neurol Res. 2011 Jan;33(1):24-32
pubmed: 20810031
Wien Klin Wochenschr. 2012 Dec;124(23-24):851-4
pubmed: 23184072
Arch Neurol. 2005 Jan;62(1):37-41
pubmed: 15642848
BMJ Case Rep. 2009;2009:
pubmed: 21709843
Nat Genet. 1992 Oct;2(2):103-6
pubmed: 1303257
Neurology. 2003 Apr 22;60(8):1351-3
pubmed: 12707442
Clin Chim Acta. 1998 May 25;273(2):161-70
pubmed: 9657346
J Pediatr. 1995 Sep;127(3):414-20
pubmed: 7658272
Hum Genet. 1996 Jul;98(1):116-8
pubmed: 8682496